Docetaxel or Cabazitaxel With or Without Darolutamide in mCRPC

NCT05762536 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

245

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer

Interventions

DRUG: Darolutamide
DRUG: Docetaxel or cabazitaxel

Sponsor

Erasmus Medical Center